,,ii  #aah? ,,congress  #a/ ,session    
,s4 #baih  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,june #bb1 #bjbc,mr4   
,b5net 7= himself & ,mr4 ,lank=d7       
introduc$ ! foll[+ bill2 :i* 0 read     
twice & ref]r$ to ! ,committee on       
,f9ance  ,a ,,bill  ,to require !       
,comptroll] ,g5]al ( ! ,unit$ ,/ates to 
conduct a /udy & submit a report on     
price-relat$ comp5sation & paym5t       
/ructures 9 ! prescription drug supply  
*a94  #a4 ,%ort title ,?is ,act may be  
cit$ z ! ,prescription ,drug ,supply    
,*a9 ,pric+ ,transp>5cy ,act4  #b4 ,,gao
 /udy & report on price-relat$          
comp5sation & paym5t /ructures 9 !      
prescription drug supply *a9 ,section   
#ahfj;,d-#db ( ! ,social ,security ,act 
7#db ,u4,s4,c4 #aciew-#aeb7 is am5d$ by 
add+ at ! end ! foll[+ new subsection3  
7e7 ,,gao /udy & report on price-,relat$
 comp5sation & paym5t /ructures 9 !     
prescription drug supply *a9  7#a7 ,/udy
 ,! ,comptroll] ,g5]al ( ! ,unit$ ,/ates
 79 ?is subsection ref]r$ to z !        

,comptroll] ,g5]al7 %all conduct a /udy 
on ! use ( comp5sation & paym5t         
/ructures relat$ to a prescription      
drug's price )9 ! retail prescription   
drug supply *a94 ,su* /udy %all include 
an ov]view ( ! foll[+3 7,a7 ,! type1    
magnitude1 o!r features 7su* z ! pric+  
b5*m>ks us$71 & preval5ce ( comp5sation 
& paym5t /ructures relat$ to a          
prescription drug's price1 su* z        
calculat+ fee am\nts z a p]c5tage ( a   
prescription drug's price1 betwe5       
int]m$i>ies 9 ! prescription drug supply
 *a91 includ+-- 7i7 ph>macy b5efit      
manag]s2  7ii7 "p ,d plan sponsors2     
7iii7 drug :olesal]s2  7iv7 ph>macies2  
7v7 manufactur]s2  7vi7 ph>macy s]vices 
adm9i/rative organizations2  7vii7      
brok]s1 auditors1 consultants1 & o!r    
entities t advise "p ,d plan sponsors   
ab\t ph>macy b5efits or review "p ,d    
plan sponsor contracts ) ph>macy b5efit 
manag]s2 &  7viii7 o!r s]vice provid]s t
 contract ) any ( ! entities describ$ 9 
clauses 7i7 ?r\gh 7vii71 includ+ rebate 

aggregators 7or o!r entities t negotiate
 or process price concessions on behalf 
( ph>macy b5efit manag]s or plan        
sponsors74  7,b7 ,! prim>y bus9ess      
models & comp5sation /ructures = ea*    
category ( int]m$i>y describ$ 9         
subp>agraph 7,a74  7,c7 ,v>iation 9     
price-relat$ comp5sation /ructures      
betwe5 affiliat$ entities 7su* z        
entities ) common own]%ip1 ei!r full or 
p>tial1 & subsidi>y relation%ips7 &     
unaffiliat$ entities4  7,d7 ,pot5tial   
conflicts ( int]e/ among contract+      
entities relat$ to ! use ( prescription 
drug price-relat$ comp5sation /ructures1
 su* z ! pot5tial = fees or o!r paym5ts 
set z a p]c5tage ( a prescription drug's
 price to advantage ! =mul>y selection1 
di/ribution1 or pur*as+ ( prescription  
drugs ) high] prices4  7,e7 ,patt]ns &  
tr5ds 9 price-bas$ comp5sation /ructures
 ov] "t & betwe5 diff]5t m>ket segm5ts1 
su* z "u ?is "p & ! ,m$icaid program "u 
title ,,xix4  7,f7 ,! factors driv+ !   
consid]ation & use ( price-relat$       

comp5sation /ructures 9 ! prescription  
drug supply *a94  7,g7 ,o!r issues      
det]m9$ to be relevant & appropriate by 
! ,comptroll] ,g5]al4  7#b7 ,report ,n  
lat] ?an #b ye>s aft] ! date ( enactm5t 
( ?is subsection1 ! ,comptroll] ,g5]al  
%all submit to ,congress a report       
conta9+ ! results ( ! /udy conduct$ "u  
p>agraph 7#a71 toge!r ) recomm5dations =
 su* legislation & adm9i/rative action z
 ! ,comptroll] ,g5]al det]m9es          
appropriate4  4